| 2QL1 | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | BMA, FUC, GAL, MAN, NAG, ZN | enzyme |
| ||||||||||||
| Primary reference | Structural characterization of a mutated, ADCC-enhanced human Fc fragment., Oganesyan V, Damschroder MM, Leach W, Wu H, Dall'acqua WF, Mol Immunol. 2008 Apr;45(7):1872-82. PMID:18078997 | ||||||||||||||
| Data retrieval |
![]() |
| View 2QL1 in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |